img
Comparative effects of high-dose atorvastatin versus rosuvastatin on lipid parameters, oxidized low-density lipoprotein, and proprotein convertase subtilisin kexin 9 in acute coronary syndrome       
Yazarlar
Bülent Behlül Altunkeser
Selçuk Üniversitesi, Türkiye
Abdullah Tunçez
Selçuk Üniversitesi, Türkiye
Bahadır Öztürk
Selçuk Üniversitesi, Türkiye
Hüseyin Tezcan
Selçuk Üniversitesi, Türkiye
Dr. Öğr. Üyesi Muhammet Salih ATEŞ
Selçuk Üniversitesi, Türkiye
Canan Yılmaz
Türkiye
Muhammed Ulvi Yalçın
Selçuk Üniversitesi, Türkiye
Nazif Aygül
Selçuk Üniversitesi, Türkiye
Kenan Demir
Selçuk Üniversitesi, Türkiye
Özet
Aim Current guidelines recommend administration of high-dose statins in acute coronary syndrome (ACS). It has been reported that statins upregulate proprotein convertase subtilisin kexin 9 (PCSK9) mRNA expression and increase circulating PCSK9 levels. We aimed to compare the effects of high-dose atorvastatin and rosuvastatin on serum oxidized low-density lipoprotein (oxidized-LDL) and PCSK9 levels in statin-naive patients with ACS. Patients and methods One hundred and six patients with ACS were enrolled in this study. The patients were assigned randomly to receive atorvastatin (80 mg/day) or rosuvastatin (40 mg/day) by using a ratio of 1 : 1 in randomization. The levels of total cholesterol (TC), triglyceride, high-density lipoprotein cholesterol, LDL-cholesterol, oxidized-LDL, and PCSK9 were compared between groups after a 4-week treatment. Results Our study population included 53 patients in the atorvastatin group (age: 58.13 +/- 11.30 years, 11.32% female) and 53 patients in the rosuvastatin group (age: 59.08 +/- 12.44 years, 15.09% female). In both groups, lipid parameters, oxidized-LDL, and PCSK9 values changed significantly according to the baseline following treatment. High-dose atorvastatin and rosuvastatin induced similar decreases in LDL-cholesterol, oxidized-LDL, and triglyceride levels and similarly increased in high-density lipoprotein cholesterol and PCSK9 levels (P>0.05). Conclusion We showed that atorvastatin and rosuvastatin treatment regimens have comparable effects on lipid parameters and PCSK9 levels in ACS patients.
Anahtar Kelimeler
acute coronary sydrome, oxidized low-density lipoprotein, proprotein convertase subtilisin kexin 9
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı Coronary Artery Disease
Dergi ISSN 0954-6928
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce
Basım Tarihi 01-2019
Cilt No 30
Sayı 4
Sayfalar 285 / 290
Doi Numarası 10.1097/MCA.0000000000000715
Makale Linki https://journals.lww.com/00019501-201906000-00007